Clinical Trials for Fibrolamellar Hepatocellular Carcinoma

Find clinical trials for fibrolamellar hepatocellular carcinoma. Discover research opportunities and treatment options in your area.

3 Active Trials Found

Showing 3 trials on this page

Page 1 of 1

DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

NCT ID: NCT06027086

This clinical trial is studying a new treatment combination for patients with advanced-stage Fibrolamellar Carcinoma (FLC), a rare type of liver cancer. The treatment involves two drugs: DRP-104, w...

Recruiting

Phase: PHASE1 Type: interventional Locations: Baltimore, Maryland, United States

FusionVAC22_01: Fusion Transcript-based Peptide Vaccine Combined with Immune Checkpoint Inhibition

NCT ID: NCT05937295

The FusionVAC22_01 clinical trial is studying a new treatment for a type of liver cancer called Fibrolamellar Hepatocellular Carcinoma (FL-HCC). This trial combines a special vaccine designed to ta...

Recruiting

Phase: PHASE1 Type: interventional Locations: Tuebingen, , Germany, Tuebingen, Baden Würtemberg, Germany

Therapeutic Assistance and Decision-making Algorithms in Hepatobiliary Tumor Boards

NCT ID: NCT05681949

This clinical trial is looking at how well an artificial intelligence system called ADBoard can help doctors make treatment recommendations for patients with liver and bile duct tumors, such as hep...

Not yet recruiting

Phase: NA Type: interventional Locations: Berlin, , Germany

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions